Zai Lab Limited EBIT

Zai Lab Limited (ZLAB) currently reports a EBIT of $-220M as of June 2026. That compares with $-240M in the prior-year period — up 6.7% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Zai Lab Limited's EBIT history and peer comparisons.

Zai Lab Limited's EBIT increased from $-240M to $-220M — a 6.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zai Lab Limited's EBIT of $-220M is lower than the Healthcare sector average of $22B. That is roughly 101.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Zai Lab Limited reported $-220M in EBIT as of June 2026. That compares with $-240M in the prior-year period — up 6.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-220M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Zai Lab Limited, and consider following ZLAB for alerts when major investors trade the stock.